GENE ONLINE|News &
Opinion
Blog

2022-07-28|

BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka

by GeneOnline
Share To

The opening session of BIO-Asia Taiwan 2022 featured a presentation by Professor Shinya Yamanaka from Japan. Prof. Yamanaka, who was awarded the Nobel Prize in Physiology and Medicine in 2012 for his iPSC research, discussed the future vision of popularizing iPSC technology with the title “Top iPS Cell Technologies at Affordable Prices”.

CiRA’s Three Major Strategies for Accelerated Production of iPSC

The CiRA Foundation (Center for iPS Cell Research Application, Kyoto University), a leading regenerative medicine research institute in Japan, was established through the efforts of Prof. Yamanaka to shorten the gap between research and industry in iPSC technology. CiRA has three main strategies to facilitate the advancement of therapeutic applications of iPSC.

It's free! Log in now to read

LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top